Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 24 (16), 3690-9

Recent Progress in Sodium Channel Modulators for Pain

Affiliations
Review

Recent Progress in Sodium Channel Modulators for Pain

Sharan K Bagal et al. Bioorg Med Chem Lett.

Abstract

Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field. Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda®, Synchropatch® and Qube®. Moreover, emerging clinical data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biology pave the way for a future of fruitful prospective Nav drug discovery.

Keywords: Electrophysiology screening; Sodium channel drugs; Sodium channel structure; Sodium channel toxins; Voltage-gated sodium channels.

Similar articles

See all similar articles

Cited by 32 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback